Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M. Prondzinsky R, et al. Among authors: werdan k. Crit Care Med. 2010 Jan;38(1):152-60. doi: 10.1097/CCM.0b013e3181b78671. Crit Care Med. 2010. PMID: 19770739 Clinical Trial.
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
Unverzagt S, Machemer MT, Solms A, Thiele H, Burkhoff D, Seyfarth M, de Waha A, Ohman EM, Buerke M, Haerting J, Werdan K, Prondzinsky R. Unverzagt S, et al. Among authors: werdan k. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007398. doi: 10.1002/14651858.CD007398.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2015 Mar 27;(3):CD007398. doi: 10.1002/14651858.CD007398.pub3. PMID: 21735410 Updated. Review.
Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial.
Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, Buerke U, Raaz U, Ebelt H, Schlitt A, Heinroth K, Haerting J, Werdan K, Buerke M. Prondzinsky R, et al. Among authors: werdan k. Shock. 2012 Apr;37(4):378-84. doi: 10.1097/SHK.0b013e31824a67af. Shock. 2012. PMID: 22266974 Clinical Trial.
Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.
Werdan K, Ruß M, Buerke M, Delle-Karth G, Geppert A, Schöndube FA; German Cardiac Society; German Society of Intensive Care and Emergency Medicine; German Society for Thoracic and Cardiovascular Surgery; (Austrian Society of Internal and General Intensive Care Medicine; German Interdisciplinary Association of Intensive Care and Emergency Medicine; Austrian Society of Cardiology; German Society of Anaesthesiology and Intensive Care Medicine; German Society of Preventive Medicine and Rehabilitation. Werdan K, et al. Dtsch Arztebl Int. 2012 May;109(19):343-51. doi: 10.3238/arztebl.2012.0343. Epub 2012 May 11. Dtsch Arztebl Int. 2012. PMID: 22675405 Free PMC article.
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
Unverzagt S, Wachsmuth L, Hirsch K, Thiele H, Buerke M, Haerting J, Werdan K, Prondzinsky R. Unverzagt S, et al. Among authors: werdan k. Cochrane Database Syst Rev. 2014 Jan 2;(1):CD009669. doi: 10.1002/14651858.CD009669.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2018 Jan 29;1:CD009669. doi: 10.1002/14651858.CD009669.pub3. PMID: 24385385 Updated. Review.
526 results